Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma

Immunoglubulin G (IgG) and its abnormal glycosylations are associated with carcinogenesis. The present study investigates the relationship between cancer-derived IgG and clinicopathological characteristics in hepatocellular carcinoma (HCC) and assesses the value of serum N-glycosylated IgG in diagno...

Full description

Saved in:
Bibliographic Details
Main Authors: Yi, Chang-Hong (Author) , Weng, Honglei (Author) , Liebe, Roman (Author) , Dooley, Steven (Author)
Format: Article (Journal)
Language:English
Published: 07 Jul 2015
In: OncoImmunology
Year: 2015, Volume: 4, Issue: 12
ISSN:2162-402X
DOI:10.1080/2162402X.2015.1011503
Online Access:Verlag, Volltext: http://dx.doi.org/10.1080/2162402X.2015.1011503
Get full text
Author Notes:Chang-Hong Yi, Hong-Lei Weng, Fei-Guo Zhou, Meng Fang, Jun Ji, Cheng Cheng, Hao Wang, Roman Liebe, Steven Dooley, Chun-Fang Gao

MARC

LEADER 00000caa a2200000 c 4500
001 1562940716
003 DE-627
005 20220813220413.0
007 cr uuu---uuuuu
008 170831s2015 xx |||||o 00| ||eng c
024 7 |a 10.1080/2162402X.2015.1011503  |2 doi 
035 |a (DE-627)1562940716 
035 |a (DE-576)492940711 
035 |a (DE-599)BSZ492940711 
035 |a (OCoLC)1340978890 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Yi, Chang-Hong  |e VerfasserIn  |0 (DE-588)1139134965  |0 (DE-627)897306031  |0 (DE-576)492940568  |4 aut 
245 1 0 |a Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma  |c Chang-Hong Yi, Hong-Lei Weng, Fei-Guo Zhou, Meng Fang, Jun Ji, Cheng Cheng, Hao Wang, Roman Liebe, Steven Dooley, Chun-Fang Gao 
264 1 |c 07 Jul 2015 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.08.2017 
520 |a Immunoglubulin G (IgG) and its abnormal glycosylations are associated with carcinogenesis. The present study investigates the relationship between cancer-derived IgG and clinicopathological characteristics in hepatocellular carcinoma (HCC) and assesses the value of serum N-glycosylated IgG in diagnosing and monitoring hepatitis B virus (HBV)-related HCC. Tissue microarray analysis of 90 HCC tissues showed that HCC patients with IgG immunopositivity had higher levels of core-fucosylated α fetoprotein (AFP-L3), larger tumors, and a higher incidence of portal vein tumor thrombus. HCC-derived IgG stimulated the growth of liver cancer cells in vitro. HCC patients presented a significantly increased fraction of Lens culinaris agglutinin binding IgG (core-fucosylated IgG, IgG-L3) among total serum IgG. The clinical diagnostic performance of serum IgG-L3% was evaluated in 3 case-control studies (1 training set and 2 validation cohorts), including 293 patients with HCC, 131 with liver cirrhosis, 132 HBV carriers, and 151 healthy controls. IgG-L3% had better general diagnostic performance than AFP in the training set and validation cohort 1 (accuracy: 81.33-85.11% versus 63.33-78.61%). In validation cohort 2, where we aimed to assess the efficiency of IgG-L3% in patients with AFP-negative HCC, the diagnostic accuracy of IgG-L3% was 72.54-73.60%. Finally, a longitudinal evaluation based on 31 HCC patients demonstrated that IgG-L3% decreased in 24 patients after curative surgery. The remaining 7 patients showed elevated IgG-L3% and post-operative recurrence. HCC patients with higher IgG-L3% had poor survival during a 3-year follow up. We conclude that HCC-derived IgG is correlated with progressive behavior of HCC. Therefore, elevated core-fucosylated IgG is a new diagnostic and prognostic marker in HBV-related HCC. 
650 4 |a diagnosis 
650 4 |a hepatocellular carcinoma (HCC) 
650 4 |a IgG 
650 4 |a Lens culinaris agglutinin (LCA) 
650 4 |a non-invasive biomarker 
650 4 |a tissue array 
700 1 |a Weng, Honglei  |d 1969-  |e VerfasserIn  |0 (DE-588)1033024074  |0 (DE-627)740785524  |0 (DE-576)38050572X  |4 aut 
700 1 |a Liebe, Roman  |e VerfasserIn  |0 (DE-588)1056006226  |0 (DE-627)793131324  |0 (DE-576)412012138  |4 aut 
700 1 |a Dooley, Steven  |d 1960-  |e VerfasserIn  |0 (DE-588)1028589190  |0 (DE-627)73128951X  |0 (DE-576)376074116  |4 aut 
773 0 8 |i Enthalten in  |t OncoImmunology  |d Abingdon : Taylor & Franics, 2012  |g 4(2015,12) Artikel-Nummer e1011503, 12 Seiten  |h Online-Ressource  |w (DE-627)683365428  |w (DE-600)2645309-5  |w (DE-576)356728366  |x 2162-402X  |7 nnas  |a Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma 
773 1 8 |g volume:4  |g year:2015  |g number:12  |g extent:12  |a Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma 
856 4 0 |u http://dx.doi.org/10.1080/2162402X.2015.1011503  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1080/2162402X.2015.1011503  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20170831 
993 |a Article 
994 |a 2015 
998 |g 1028589190  |a Dooley, Steven  |m 1028589190:Dooley, Steven  |d 60000  |d 61100  |e 60000PD1028589190  |e 61100PD1028589190  |k 0/60000/  |k 1/60000/61100/  |p 9 
998 |g 1056006226  |a Liebe, Roman  |m 1056006226:Liebe, Roman  |d 60000  |d 61100  |e 60000PL1056006226  |e 61100PL1056006226  |k 0/60000/  |k 1/60000/61100/  |p 8 
998 |g 1033024074  |a Weng, Honglei  |m 1033024074:Weng, Honglei  |d 60000  |d 61100  |e 60000PW1033024074  |e 61100PW1033024074  |k 0/60000/  |k 1/60000/61100/  |p 2 
999 |a KXP-PPN1562940716  |e 297893798X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"role":"aut","display":"Yi, Chang-Hong","given":"Chang-Hong","family":"Yi"},{"display":"Weng, Honglei","role":"aut","family":"Weng","given":"Honglei"},{"given":"Roman","family":"Liebe","role":"aut","display":"Liebe, Roman"},{"family":"Dooley","given":"Steven","display":"Dooley, Steven","role":"aut"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1562940716"],"doi":["10.1080/2162402X.2015.1011503"]},"physDesc":[{"extent":"12 S."}],"relHost":[{"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"OncoImmunology","title_sort":"OncoImmunology"}],"disp":"Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinomaOncoImmunology","note":["Gesehen am 13.12.2022"],"id":{"zdb":["2645309-5"],"issn":["2162-402X"],"eki":["683365428"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"text":"4(2015,12) Artikel-Nummer e1011503, 12 Seiten","issue":"12","extent":"12","year":"2015","volume":"4"},"pubHistory":["1.2012 -"],"titleAlt":[{"title":"Onco Immunology"}],"recId":"683365428","origin":[{"dateIssuedKey":"2012","publisherPlace":"Abingdon ; Austin, Tex.","dateIssuedDisp":"2012-","publisher":"Taylor & Franics ; Landes Bioscience"}]}],"title":[{"title_sort":"Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma","title":"Elevated core-fucosylated IgG is a new marker for hepatitis B virus-related hepatocellular carcinoma"}],"recId":"1562940716","name":{"displayForm":["Chang-Hong Yi, Hong-Lei Weng, Fei-Guo Zhou, Meng Fang, Jun Ji, Cheng Cheng, Hao Wang, Roman Liebe, Steven Dooley, Chun-Fang Gao"]},"note":["Gesehen am 31.08.2017"],"origin":[{"dateIssuedDisp":"07 Jul 2015","dateIssuedKey":"2015"}]} 
SRT |a YICHANGHONELEVATEDCO0720